Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis : a cross-sectional analysis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:82 |
|---|---|
| Enthalten in: |
Annals of the rheumatic diseases - 82(2023), 12 vom: 15. Dez., Seite 1638-1640 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Qiu, Yoon Y [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 13.11.2023 Date Revised 09.12.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1136/ard-2023-224492 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM359686761 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM359686761 | ||
| 003 | DE-627 | ||
| 005 | 20231227131413.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/ard-2023-224492 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM359686761 | ||
| 035 | |a (NLM)37468220 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Qiu, Yoon Y |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Anti-cyclic citrullinated peptide antibody and pain sensitisation in patients with rheumatoid arthritis |b a cross-sectional analysis |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 13.11.2023 | ||
| 500 | |a Date Revised 09.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Anti-Citrullinated Protein Antibodies | |
| 650 | 4 | |a Arthritis, Rheumatoid | |
| 650 | 4 | |a Patient Reported Outcome Measures | |
| 650 | 7 | |a Autoantibodies |2 NLM | |
| 650 | 7 | |a Peptides |2 NLM | |
| 650 | 7 | |a Peptides, Cyclic |2 NLM | |
| 700 | 1 | |a Neogi, Tuhina |e verfasserin |4 aut | |
| 700 | 1 | |a Muhammad, Lutfiyya N |e verfasserin |4 aut | |
| 700 | 1 | |a Song, Jing |e verfasserin |4 aut | |
| 700 | 1 | |a Bolster, Marcy B |e verfasserin |4 aut | |
| 700 | 1 | |a Marder, Wendy |e verfasserin |4 aut | |
| 700 | 1 | |a Heisler, Andrew C |e verfasserin |4 aut | |
| 700 | 1 | |a Wohlfahrt, Alyssa |e verfasserin |4 aut | |
| 700 | 1 | |a Dunlop, Dorothy |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Yvonne C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of the rheumatic diseases |d 1939 |g 82(2023), 12 vom: 15. Dez., Seite 1638-1640 |w (DE-627)NLM000174114 |x 1468-2060 |7 nnns |
| 773 | 1 | 8 | |g volume:82 |g year:2023 |g number:12 |g day:15 |g month:12 |g pages:1638-1640 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/ard-2023-224492 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 82 |j 2023 |e 12 |b 15 |c 12 |h 1638-1640 | ||